Jordi Salas-Salvadó

Human Nutrition Unit, Faculty of Medicine and Health Sciences, Rovira i Virgili University, Reus and CIBEROBN, Instituto de Salud Carlos III, Spain.


Biography

Professor and director of the Human Nutrition Unit, Department of Biochemistry & Biotechnology at the Rovira i Virgili University (URV), Spain. Head of Nutrition Section at the Internal Medicine Service, at the Sant Joan University Hospital of Reus (HUSJR). Vice-President of the Pere Virgili Institute of Health Research (IISPV). Principal investigator of the CIBER Physiopathology of Obesity and Nutrition (CIBERobn), at the Institute of Health Carlos III, and coordinator of its Nutrition Program. Director of Centre Català de la Nutrició at Institut d'Estudis Catalans (CCNIEC), and also member of Insitut d’Estudis Catalans (IEC). Director of the Iberoamerican Network on metabolic syndrome (RIBESMET). Chairman of the World Forum for Nutrition Research and Dissemination (INC). Member of the Spanish Agency for Food Safety. Member of the Academy of Medical Sciences of Catalonia and the Balearic Islands. Member of the Spanish Academy of Nutrition. Past-president of the Federation of Spanish Food, Nutrition and Dietetic Scientific Societies (2010-2015).

In last years, Dr. Salas’ expertise and research lines focuses on human clinical trials evaluating the effect of diets and dietary compounds on obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. Since 2005, he is one of the leaders of the PREDIMED STUDY, a landmark trial evaluating the effect of the Mediterranean Diet on the primary prevention of cardiovascular diseases. He is the Director and Chair of the Steering Committee of the PREDIMED-PLUS STUDY, a multi-centre, randomised, primary prevention trial on 6,900 overweight or obese participants (aged, 55-75 years) with metabolic syndrome. The project aims to determine the effects on cardiovascular disease events and mortality, adiposity, cardiovascular risk factors and quality of life, of an intensive weight loss intervention based on a traditional hypocaloric Mediterranean Diet, physical activity promotion and behavioral support compared to a less intensive program using Mediterranean Diet (without energy restriction or physical activity). The recruitment started in September 2013 and finished in November 2016. Results will be available in 2020.

Since 1983 Dr. Salas has directed 17 research projects funded by public bodies (DGICYT, Instituto de Cooperación Iberoamericana, Fondo de Investigaciones de la Seguridad Social, PROFIT, CICYT and the European Society of Parenteral and Enteral Nutrition) and 25 projects in conjunction with pharmaceutical and food industries. He has also taken part as a co-researcher and co-IP in other projects funded by the FIS, the European Commission and the Institute of Health Studies of the Catalan Government. He has published more than 400 original articles in national and international journals, as well as numerous reviews and editorials. Editor of 6 books, he has also co-authored more than 50. He has presented about 400 communications at national and international congresses.